These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6521021)

  • 1. [Immunohistological detection of monoclonal antibodies to histocompatibility antigens in melanoma cells and nevus cells].
    Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K
    Nihon Hifuka Gakkai Zasshi; 1984 Oct; 94(11):1285-9. PubMed ID: 6521021
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
    Ruiter DJ; Bergman W; Welvaart K; Scheffer E; van Vloten WA; Russo C; Ferrone S
    Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
    Ruiter DJ; Bhan AK; Harrist TJ; Sober AJ; Mihm MC
    J Immunol; 1982 Dec; 129(6):2808-15. PubMed ID: 6183345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of antigens 15.75 and p3.58 on primary melanoma and benign nevi.
    Holzmann B; Johnson JP; Kaudewitz P; Braun-Falco O; Riethmüller G
    Behring Inst Mitt; 1984 May; (74):24-6. PubMed ID: 6477355
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.
    van Duinen SG; Ruiter DJ; Broecker EB; van der Velde EA; Sorg C; Welvaart K; Ferrone S
    Cancer Res; 1988 Feb; 48(4):1019-25. PubMed ID: 3338074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of monoclonal antibody 225.28S in the study of nevus cells in culture].
    Raffaelli M; Fimiani M; Castelli A; Mancianti ML; Valentino A; Andreassi L
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):467-71. PubMed ID: 6370274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M; Guerry D; Koprowski H
    J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma.
    Steplewski Z; Herlyn M; Herlyn D; Clark WH; Koprowski H
    Eur J Immunol; 1979 Jan; 9(1):94-6. PubMed ID: 374094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies.
    Imai K; Ng AK; Glassy MC; Ferrone S
    J Immunol; 1981 Aug; 127(2):505-9. PubMed ID: 6166672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistological evaluation of melanoma using anti-human melanoma monoclonal antibody].
    Kageshita T; Jono M; Ono T; Arao T; Imai K
    Nihon Hifuka Gakkai Zasshi; 1983 Apr; 93(5):537-40. PubMed ID: 6352996
    [No Abstract]   [Full Text] [Related]  

  • 17. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC antigens in human melanomas.
    Ruiter DJ; Mattijssen V; Broecker EB; Ferrone S
    Semin Cancer Biol; 1991 Feb; 2(1):35-45. PubMed ID: 1912517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.
    Rudolph P; Lappe T; Schubert C; Schmidt D; Parwaresch RM; Christophers E
    Am J Pathol; 1995 Dec; 147(6):1615-25. PubMed ID: 7495287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.